[Endocrine ophthalmopathy in Graves disease during antithyroid drug therapy (author's transl)].
D013956:Antithyroid Agents / Q000627:therapeutic use*; D005260:Female; D006111:Graves Disease / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D008297:Male; D013963:Thyroid Hormones / Q000502:physiology; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D013956:Antithyroid Agents; D013963:Thyroid Hormones; D014284:Triiodothyronine; D013972:Thyrotropin; D013974:Thyroxine
Die endokrine Orbitopathie bei diffuser Hyperthyreose unter thyreostatischer Therapie.